Human ACE2 peptide-mimics block SARS-CoV-2 pulmonary cells infection
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Human ACE2 peptide-mimics block SARS-CoV-2 pulmonary cells infection
Authors
Keywords
-
Journal
Communications Biology
Volume 4, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-02-12
DOI
10.1038/s42003-021-01736-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A novel coronavirus outbreak of global health concern
- (2020) Chen Wang et al. LANCET
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2
- (2020) Renhong Yan et al. SCIENCE
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
- (2020) Daniel Wrapp et al. SCIENCE
- Computational Design of ACE2-Based Peptide Inhibitors of SARS-CoV-2
- (2020) Yanxiao Han et al. ACS Nano
- Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
- (2020) Vanessa Monteil et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody
- (2020) Dora Pinto et al. NATURE
- Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
- (2020) Jun Lan et al. NATURE
- Structural basis of receptor recognition by SARS-CoV-2
- (2020) Jian Shang et al. NATURE
- These drugs don’t target the coronavirus—they target us
- (2020) Kai Kupferschmidt SCIENCE
- An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice
- (2020) Timothy P. Sheahan et al. Science Translational Medicine
- In silico design of antiviral peptides targeting the spike protein of SARS-CoV-2
- (2020) Rongsong Ling et al. PEPTIDES
- De novo design of picomolar SARS-CoV-2 miniprotein inhibitors
- (2020) Longxing Cao et al. SCIENCE
- Therapeutic peptides: Historical perspectives, current development trends, and future directions
- (2018) Jolene L. Lau et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Peptide therapeutics: current status and future directions
- (2015) Keld Fosgerau et al. DRUG DISCOVERY TODAY
- Stabilized Helical Peptides: A Strategy to Target Protein–Protein Interactions
- (2014) Mark A. Klein ACS Medicinal Chemistry Letters
- Helix propensities of the amino acids measured in alanine-based peptides without helix-stabilizing side-chain interactions
- (2010) Avijit Chakrabartty et al. PROTEIN SCIENCE
- Synthetic therapeutic peptides: science and market
- (2009) Patrick Vlieghe et al. DRUG DISCOVERY TODAY
- Homotyrosine-Containing Cyanopeptolins 880 and 960 and Anabaenopeptins 908 and 915 fromPlanktothrix agardhiiCYA 126/8
- (2008) Hilary S. Okumura et al. JOURNAL OF NATURAL PRODUCTS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started